GYKI 66131
Latest Information Update: 29 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 24 May 1999 New profile
- 24 May 1999 Preclinical development for Thrombosis in Hungary (Unknown route)